The best indicator for Accenture (ACN)
We backtested 20 indicators across daily, weekly and hourly charts on real Accenture (ACN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Rate of Change
On the weekly chart, this is the strongest risk-adjusted edge we found for Accenture (ACN) over ~25.0 years — trailing buy-and-hold by 4.7% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Rate of Change ✓ | Weekly | 7.4% | 0.47 | -33.4% | 49.4% | 77 | -4.7% |
| 2 | SMA 50/200 Cross ✓ | Daily | 6.9% | 0.43 | -36.3% | 50.0% | 18 | -5.2% |
| 3 | EMA 20/50 Cross ✓ | Daily | 6.9% | 0.43 | -46.9% | 45.1% | 51 | -5.2% |
| 4 | EMA-10 Trend ✓ | Weekly | 5.7% | 0.39 | -40.5% | 45.0% | 111 | -6.4% |
| 5 | EMA 50/200 Cross ✓ | Daily | 9.2% | 0.53 | -37.7% | 63.6% | 11 | -2.9% |
| 6 | Donchian Midline ✓ | Weekly | 5.6% | 0.38 | -42.6% | 47.1% | 70 | -6.5% |
| 7 | Rate of Change ✓ | Daily | 4.9% | 0.34 | -51.5% | 41.5% | 376 | -7.1% |
| 8 | Holy Grail Confluence ✓ | Daily | 4.8% | 0.34 | -44.3% | 68.4% | 38 | -7.3% |
| 9 | Stochastic | Daily | 4.6% | 0.33 | -42.0% | 69.8% | 116 | -7.5% |
| 10 | WaveTrend (8/6/4) ✓ | Weekly | 4.4% | 0.33 | -41.5% | 78.9% | 19 | -7.6% |
| 11 | RSI Trend (>50) ✓ | Weekly | 4.4% | 0.32 | -47.0% | 57.9% | 76 | -7.6% |
| 12 | Donchian Breakout ✓ | Weekly | 3.8% | 0.3 | -32.7% | 60.0% | 20 | -8.3% |
| 13 | WaveTrend (8/6/4) ✓ | Daily | 4.1% | 0.29 | -51.0% | 76.5% | 85 | -8.0% |
| 14 | Williams %R ✓ | Weekly | 3.6% | 0.28 | -50.2% | 67.6% | 34 | -8.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Accenture (ACN), Rate of Change on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.